Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines-Reference-Cited by-同舟云学术

Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines

Published:2017-04 Issue: Volume:27 Page:1-7
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Juengel Eva,Euler Stephanie,Maxeiner Sebastian,Rutz Jochen,Justin Saira,Roos Frederik,Khoder Wael,Nelson Karen,Bechstein Wolf O.,Blaheta Roman A.^ORCID

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference32 articles.

1. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer;Alumkal;Invest. New Drugs,2015

2. Sulforaphane bioavailability and chemopreventive activity in women scheduled for breast biopsy;Atwell;Cancer Prev. Res.,2015

3. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation;Chen;Exp. Cell Res.,2013

4. Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer;Chen;J. Mol. Med.,2010

5. Sulforaphane attenuates EGFR signaling in NSCLC cells;Chen;J. Biomed. Sci.,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-01

2. Mechanistic and Clinical Chemoprevention;Reference Module in Biomedical Sciences;2024

3. Multiomics integration reveals the effect of Orexin A on glioblastoma;Frontiers in Pharmacology;2023-01-20

4. Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms;Cancers;2022-07-04

5. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway;Cancers;2022-02-22